Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku, Karolina Krassowska, Robin Fox, Ian Binnian, Victoria Glover, Stephen Bright, Christopher Butler, Jennifer L Cane, Andreas Halner, Philippa C Matthews, Louise E Donnelly, Jodie L Simpson, Jonathan R Baker, Nabil T Fadai, Stefan Peterson, Thomas Bengtsson, Peter J Barnes, Richard E K Russell, Mona Bafadhel

Open source

DOI: 10.1016/s2213-2600(21)00160-0
Published: 2021-07
Container: The Lancet Respiratory Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-21-00160-0,
  title = {Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial},
  author = {Sanjay Ramakrishnan and Dan V Nicolau and Beverly Langford and Mahdi Mahdi and Helen Jeffers and Christine Mwasuku and Karolina Krassowska and Robin Fox and Ian Binnian and Victoria Glover and Stephen Bright and Christopher Butler and Jennifer L Cane and Andreas Halner and Philippa C Matthews and Louise E Donnelly and Jodie L Simpson and Jonathan R Baker and Nabil T Fadai and Stefan Peterson and Thomas Bengtsson and Peter J Barnes and Richard E K Russell and Mona Bafadhel},
  year = {2021},
  journal = {The Lancet Respiratory Medicine},
  doi = {10.1016/s2213-2600(21)00160-0},
  url = {https://doi.org/10.1016/s2213-2600(21)00160-0}
}

RIS

TY  - JOUR
TI  - Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
AU  - Sanjay Ramakrishnan
AU  - Dan V Nicolau
AU  - Beverly Langford
AU  - Mahdi Mahdi
AU  - Helen Jeffers
AU  - Christine Mwasuku
AU  - Karolina Krassowska
AU  - Robin Fox
AU  - Ian Binnian
AU  - Victoria Glover
AU  - Stephen Bright
AU  - Christopher Butler
AU  - Jennifer L Cane
AU  - Andreas Halner
AU  - Philippa C Matthews
AU  - Louise E Donnelly
AU  - Jodie L Simpson
AU  - Jonathan R Baker
AU  - Nabil T Fadai
AU  - Stefan Peterson
AU  - Thomas Bengtsson
AU  - Peter J Barnes
AU  - Richard E K Russell
AU  - Mona Bafadhel
PY  - 2021
JO  - The Lancet Respiratory Medicine
DO  - 10.1016/s2213-2600(21)00160-0
UR  - https://doi.org/10.1016/s2213-2600(21)00160-0
ER  -

APA

Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., Bright, S., Butler, C., Cane, J. L., Halner, A., Matthews, P. C., Donnelly, L. E., Simpson, J. L., Baker, J. R., Fadai, N. T., Peterson, S., Bengtsson, T., Barnes, P. J., Russell, R. E. K., & Bafadhel, M. (2021). Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(21)00160-0

Source records

crossref · retrieved 2026-09-26T09:31:49.859Z